Updated:
Spray Venture Partners
Spray Venture Partners invests in emerging healthcare technology companies. The firm partners with clinical and technical founders to develop innovative...
Spray Venture Partners
Spray Venture Partners invests in emerging healthcare technology companies. The firm partners with clinical and technical founders to develop innovative technologies. Spray Venture Partners has made 62 investments, including a Series E - II investment in Solace Therapeutics on February 12, 2020.
General information
Firm type
Venture Capital
Year founded
1996
Location
Region
North America
Country
United States
City
Newton
Corporate office
Newton, MA, United States
Frequently asked questions
Who runs investment decisions at Spray Venture Partners?
No named principals or investment committee members are publicly associated with Spray Venture Partners. Regulatory filings, press releases, and industry databases contain no leadership roster.
Does Spray Venture Partners have a disclosed fund or investment vehicle?
There are no public records of a named fund vehicle, Form ADV filing, or SEC registration attributable to Spray Venture Partners. The firm's fundraising history, if any, is not disclosed.
What is Spray Venture Partners' investment stage and sector focus?
Altss records indicate the firm targets early-stage through late-stage venture capital broadly, without specifying named sectors. No portfolio company names or sector concentrations have been publicly confirmed.
How much capital does Spray Venture Partners manage?
Spray Venture Partners has not publicly disclosed assets under management. The firm does not appear in any public AUM databases or regulatory reports, making an estimate impossible.
Is Spray Venture Partners still actively investing?
The firm's current operational status is unclear. No press releases, portfolio company announcements, SEC filings, or website updates exist to confirm active investment activity.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: